Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3734186015 | Ocrelizumab only product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3734187012 | Product containing only ocrelizumab (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 521881000188113 | médicament contenant seulement ocrélizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 781101000241110 | médicament contenant seulement ocrélizumab (produit médicinal) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ocrelizumab only product | a pour principe actif (attribut) | Ocrelizumab | true | Inferred relationship | Some | 1 | |
| Ocrelizumab only product | est un(e) (attribut) | Product containing ocrelizumab (medicinal product) | true | Inferred relationship | Some | ||
| Ocrelizumab only product | Count of base of active ingredient | un | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ocrelizumab only product in parenteral dose form | est un(e) (attribut) | True | Ocrelizumab only product | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
FHIR